You are here

Article Text

Article menu
Download PDFPDF
Case report
Idiopathic bilateral ovarian vein thrombosis
  1. Joshua Christy,
  2. Divya Jarugula,
  3. Kavitha Kesari and
  4. Arvind Kunadi
  1. Internal Medicine, McLaren Regional Medical Center, Flint, Michigan, USA
  1. Correspondence to Dr Joshua Christy; joshua.christy{at}mclaren.org

Abstract

Ovarian vein thrombosis (OVT) is a condition most commonly associated with malignancy, hypercoagulable disorders, pelvic surgery, trauma, inflammatory bowel disease and the postpartum period. Idiopathic bilateral OVT is extremely rare. We report the case of a 30-year-old African-American woman who presented with bilateral lower pelvic pain and nausea. She had no recent pelvic infections nor a personal or family history of malignancy or thrombophilia. Workup results for a hypercoagulable state was negative. A CT scan of the abdomen and pelvis revealed bilateral OVT. Treatment included novel oral anticoagulants or warfarin, with comparison studies showing a similar risk–benefit ratio. Repeat imaging is recommended after 40–60 days to determine the necessity for further anticoagulation. Emphasis is placed on starting anticoagulation early in order to reduce the risk of extension of the thrombus into the inferior vena cava, conversion to pulmonary embolism or increase in the risk of infection.

  • haematology (incl blood transfusion)
  • obstetrics and gynaecology

https://doi.org/10.1136/bcr-2020-238243

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors JC has provided substantial contribution to conception and design of the work, acquired data for the work, drafting the work and revising it for critically important intellectual content, final approval of version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to integrity of any part of the work are appropriately investigated and resolved. DJ has provided substantial contribution to conception and design of the work, acquired data for the work, drafting the work and revising it for critically important intellectual content, final approval of version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to integrity of any part of the work are appropriately investigated and resolved. KK has provided substantial contribution to conception and design of the work, acquired data for the work, drafting the work and revising it for critically important intellectual content, final approval of version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to integrity of any part of the work are appropriately investigated and resolved. AK has provided substantial contribution to conception and design of the work, acquired data for the work, drafting the work and revising it for critically important intellectual content, final approval of version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to integrity of any part of the work are appropriately investigated and resolved.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.